A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
PHASE1RecruitingINTERVENTIONAL
Enrollment
78
Participants
Timeline
Start Date
June 6, 2025
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG
Retatrutide
Administered SC
DRUG
Placebo
Administered SC
Trial Locations (1)
8010
RECRUITING
Medizinische Universität Graz, Graz
All Listed Sponsors
lead
Eli Lilly and Company
INDUSTRY
NCT06982846 - A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia | Biotech Hunter | Biotech Hunter